Program

Program at a glance

*tentative (Last Updated: 2025-08-08)

Program at a glance

Special LectureNov.14, (Fri)11:30-12:10 (Noh Theatre)

Unmet Needs for Hemophilia Treatment and Management
Moderator
Midori Shima (Thrombosis and Hemostasis Research Center, Nara Medical University)
Speaker
Pantep Angchaisuksiri (Ramathibodi Hospital, Mahidol University)

Sponsored Symposium 1 Nov.13(Thu)16:50-18:30 (Noh Theatre)

Sponsored by CHUGAI PHARMACEUTICAL

Advancing Hemophilia A Care: Insights from Asia on Hemlibra's Efficacy and Experience
Moderator
Ei Kinai（Clinical Laboratory Medicine, Tokyo Medical University）
Renchi Yang （National Hemophilia Registry Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College）
Speaker
Current status and future perspective on hemophilia care in China Mainland
Renchi Yang  (National Hemophilia Registry Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College)
From clinical trials to real world practice of hemophilia A patients
Yeu-Chin Chen (Hemophilia care and research center  in Tri-Service General Hospital)
Real-World Evidence of Emicizumab in Korea(가안)
Seung Min Hahn  (Department of Pediatrics, Severance Hospital Yonsei University College of Medicine)
Efficacy and safety of Hemlibra　～Update the evidence～
Ei Kinai  (Clinical Laboratory Medicine, Tokyo Medical University)

Sponsored Symposium 2Nov.14(Fri)9:50-11:30 (Noh Theatre)

Sponsored by Novo Nordisk Pharma

Alhemo® in haemophilia, what unmet needs does an anti-TFPI rebalancing agent address?
Moderator
Nobuaki Suzuki (Department of Transfusion Medicine, Nagoya University Hospital)
Midori Shima (Thrombosis and Hemostasis Research Center, Nara Medical University)
Speaker
Mechanism of anti-TFPI rebalancing therapy with Alhemo® and its clinical outcome
Seung Min Hahn (Pediatric Oncology Center, Yonsei Cancer Hospital)
Safety and efficacy of concizumab prophylaxis in people with hemophilia A or hemophilia B without inhibitors in phase 3a trial explorer8
Pratima Chowdary (Haemophilia and Haemostasis, University College London, Katharine Dormandy Haemophilia & Thrombosis Centre Royal Free Hospital)

Sponsored Symposium 3　Nov.14(Fri)13:20-15:00 (Noh Theatre)

Sponsored by Takeda Pharmaceutical

Current situation of von Willebrand Disease
Moderator
Kenichi Ogiwara (Department of Padiatrics, Nara Medical University)
Speaker
Hu Yu
Yeu-Chin Chen
Kun Soo Lee
Kenichi Ogiwara (Department of Padiatrics, Nara Medical University)

Sponsored Symposium 4　Nov.14(Fri)15:10-16:50 (Noh Theatre)

Sponsored by CSL Behring

CSL Medical Affairs Symposium
Advancing to a new treatment paradigm: Gene Replacement Therapy
Moderator
Eun Jin Choi (Daegu Catholic University Medical Center)
Speaker
Gene Therapy in Japan：regulatory aspects and current clinical set-up
Yoshikazu Yonemitsu (R&D Laboratory for Innovative Biotherapeutics Kyushu University Graduate School of Pharmaceutical Sciences)
Implementing Shared Decision-Making in Hemophilia Care
Azusa Nagao (Department of Hematology-Oncology, Kansai Medical University Hospital)
Gene Therapy for Hemophilia: Translating Clinical Trial Experiences to Real-World in Taiwan
Sheng-Chieh, Chou (Department of Internal Medicine, National Taiwan University Hospital (NTUH))

Sponsored Symposium 5　Nov.15(Sat)9:50-11:30 (Noh Theatre)

Sponsored by Sanofi

Evolving ecosystems for Hemophilia Care in East Asia: Country Models and Collaborative Innovation
Moderator
Masahiro Takeyama (Division of Hemophilia, Osaka National Hospital)
Ming-Ching Shen (Department of Internal Medicine, Changhua Christian Hospital)
Speaker
Building a Regional Hemophilia Network in Japan: A Block Hemophilia Center’s Experience in Multidisciplinary and Inter-Hospital Collaboration and Registry Launch
Masahiro Takeyama (Division of Hemophilia, Osaka National Hospital)
Advancing Comprehensive Hemophilia Care in Korea: The Role of the Korea Hemophilia Foundation
Hong hoe Koo (Korea Hemophilia Foundation)
Advancing Hemophilia A Care in Taiwan: A Model of Comprehensive Treatment and Data-Driven Collaboration
Shyh-Shin Chiou (1.College of Medicine, Kaohsiung Medical University
2. Department of Pediatrics, Kaohsiung Medical University Hospital)
Hemophilia Center Evaluation and Accreditation Project in China: Advancing Tiered, Equitable Care for Hemophilia Patients
Feng Xue　(Chinese Academy of Medical Sciences & Peking Union Medical College Hospital of Hematology)

Welcome Seminar 1Nov.13(Thu)16:00-16:45 (Noh Theatre)

Sponsored by Novo Nordisk Pharma

Moderator
Takeshi Matsumoto (Department of Transfusion Medicine and Cell Therapy, Saitama Medical Center)
Speaker
Management Strategies for Hemophilia and Associated Comorbidities
Jiaan-Der-Wang (Center for Rare Disease and Hemophilia, Taichung Veterans General Hospital)

Welcome Seminar 2Nov.13(Thu)16:00-16:45 (Conference Room 1)

Sponsored by CSL Behring

A Comprehensive Review of rFIX-FP Phase 3 Trials and Real-World Data, from Pediatric to Elderly Populations
Moderator
Pantep Angchaisuksiri (Ramathibodi Hospital, Mahidol University)
Speaker
Current situation of peoples with hemophilia B in Japan and practical sharing of clinical experience in IDELVION
Keiji Nogami (Department of Pediatrics, Nara Medical University)

Morning Seminar 1Nov.14(Fri)08:00-08:45 (Conference Room 1)

Sponsored by KM Biologics

Moderator
Sang Kyu Park (Korea Hemophilia Foundation Busan Clinic)
Speaker
The usefulness of pd-FVIIa/FX in hemostatic treatment of hemophilia inhibitors
Yuto Nakajima (Department of Pediatrics, Nara Medical University)
Understanding the bypass pathways of coagulation : For management of optimal hemostasis in patients with inhibitors
Mitsuhiro Uchiba (Department of Transfusion Medicine and Cell Therapy, Kumamoto University Hospital)

Morning Seminar 2Nov.15(Sat)08:00-08:45 (Conference Room 1)

Sponsored by SEKISUI CHEMICAL

Moderator
Ki-Young Yoo (Korea Hemophilia Foundation, Seoul clinic)
Speaker
Clinical application and advances of clot waveform analysis in the hemorrhagic and thrombotic disorders
Keiji Nogami (Department of Pediatrics, Nara Medical University)

Luncheon Seminar 1Nov.14(Fri)12:20-13:05 (Conference Room 1)

Sponsored by Pfizer Japan

Anti-TFPI Agent
Moderator
Teruhisa Fujii
Speaker
Marstacimab: Rational for fixed dose and the latest safety and efficacy data from the Phase 3 BASIS study
Johnny Mahlangu (Department of Molecular Medicine and Haematology, Univerity of the Witwatersrand)

Luncheon Seminar 2　Nov.14(Fri)11:40-12:25 (Conference Room 1)

Sponsored by Japan Blood Products Organization

Hemophilia in Japan and around the world
Moderator
Tai Ju Hwang (Chonnam National University)
Speaker
Global trends in the hemophilia healthcare environment and WFH (World Federation of Hemophilia)
Yasuharu Nishida (Division of Hemophilia, Osaka National Hospital)
Healthcare of Haemophilia in Japan, Historical Issues and Current Challenges, and Future Strategies
Katsuyuki Fukutake (Ogikubo Hospital)

Evening Seminar 1Nov.14(Fri)18:00-18:45 (Noh Theatre)

Sponsored by CHUGAI PHARMACEUTICAL

From Current Excellence to Future Breakthroughs: The Evolution of Hemophilia A Treatment
Moderator
Runhui Wu (Beijing Children’s Hospital, Capital Medical University)
Speaker
Recent Advances and Future Directions in Hemlibra Therapy for
Hemophilia   A
Keiji Nogami (Department of Pediatrics, Nara Medical University)

Evening Seminar 2Nov.14(Fri)18:00-18:45 (Conference Room 1)

Sponsored by Sanofi

Advancing Hemophilia A Care: ALTUVIIIO's Impact Across Age Groups and Regions
Moderator
Chia-Yau Chang (Taipei Medical University Hospital)
Speaker
Clinical Insights into ALTUVIIIO in Hemophilia A: Trial Evidence and Real world Clinical Experience of Product Switching in Multi-centers in Taiwan
Chia-Yau Chang　(Taipei Medical University Hospital)
ALTUVIIIO in Children with Hemophilia A: Clinical Insights from the XTEND-Kids Study and Real-World Experience from a Single Center
Rie Shirayama (University of Occupational and Environmental Health)

Farewell SeminarNov.15(Sat)12:40-13:25 (Noh Theatre)

Sponsored by Bayer Yakuhin

Moderator
Tadashi Matsushita (Department of Transfusion Medicine, Nagoya University Hospital)
Speaker
Simplicity Through Mastery, Proven by Time: Recombinant FVIII
– The Cornerstone of Hemophilia Treatment
Renchi Yang (Institute of Haematology and Blood Diseases Hospital)

General Session 1Nov.13(Thu)15:10-16:00 (Noh Theatre)

Current Situation of Hemophilia
Current Status of Hemophilia Treatment in Japan
Moderator
TBA
Speaker
TBA

General Session 2Nov.13(Thu)15:10-16:00 (Conference Room 1)

Basic Science / Novel Therapy
Moderator
TBA
Speaker
TBA

General Session 3 Nov.14(Fri)09:00-09:50 (Noh Theatre)

Carriers of Hemophilia
Moderator
TBA
Speaker
TBA

General Session 4Nov.14(Fri)09:00-09:50 (Conference Room 1)

Aging / Comorbidities
Moderator
TBA
Speaker
TBA

General Session 5Nov.15(Sat)09:00-09:50 (Noh Theatre)

Registry / Care Network
Moderator
TBA
Speaker
TBA

General Session 6Nov.15(Sat)09:00-09:50 (Conference Room 1)

Joint Health (Assessment / Surgery / Rehabilitation)
Moderator
TBA
Speaker
TBA
BACK TO TOP